Pfizer loses out on Viagra patent in Canada; Hospira ramps back up to re-supply scarce drugs;

@FiercePharma: Will Merck's Oxytrol benefit from new FDA interest in OTC access? More | Follow @FiercePharma

> Generics makers may start producing versions of Viagra in Canada after a court ruled Pfizer's ($PFE) patent was invalid. Report

> Hospira ($HSP) is slowly ramping up production at the manufacturing plants it has been upgrading to get critical drugs back to the market, CEO Michael Ball told analysts Wednesday. Report

> Ranbaxy Laboratories topped estimates with $140 million in profits for the quarter, thanks for strong North American demand; sales grew to 26.5 billion rupees ($487 million). Report

> Cancer patients taking statin drugs were 15% less likely to die than patients who weren't using the drugs. Report

> Germany's largest independent generic drugmaker Stada confirmed its outlook for earnings growth this year as it expands in eastern Europe. Report

Medical Device News

 @FierceMedDev: Theragenics faced slumping revenue in Q3. The device maker blames hc reform, the device tax and economic uncertainty. More | Follow @FierceMedDev

 @MarkHFierce: OraSure's new HIV rapid Dx test helped reduce losses in Q3. News | Follow @MarkHFierce

 @DamianFierce: Boston Sci is now a hypertension player, spending $425M on Vessix, a Fierce 15 winner. More | Follow @DamianFierce

> GenMark's revenue soars as loss narrows. News

> Bausch + Lomb snatches up ophthalmology laser startup. Item

Biotech News

 @FierceBiotech: After cashing in on life-saving boast, biotech stayed mum on patient death. Story | Follow @FierceBiotech

 @JohnCFierce: Catalyst $CPRX cocaine addiction drug flops in phase IIb, shares down 65%--a penny stock now. More | Follow @JohnCFierce

 @RyanMFierce: GNS Healthcare, Mt. Sinai and Farber want to drop a Big Data bomb on cancer with a computer model of mult. myeloma. Release | Follow @RyanMFierce

> FDA experts give Novartis' Cushing's drug unanimous endorsement. Story

> BioCryst scraps $235M late-stage flu drug program backed by feds. Article

> Novartis R&D spotlights blockbuster hopefuls, promises 14 big approvals. News

Vaccine News

 @AlisonBFierce: The percentage of drug-resistant malaria cases is on the rise in Southeast Asia, a cause for concern among experts. News | Follow @AlisonBFierce

> GSK withdraws infant vaccine in Canada. Article

> BiondVax, MonoSol Rx develop oral universal flu vaccine. News

> Scripps researchers develop methamphetamine vaccine. Story

> PsiOxus lands $2.7M for ovarian cancer vaccine trial. Item

Pharma Manufacturing News

> African raids seize 82M doses of counterfeits. Report

> Another online seller of fake Viagra heads for jail. Story

> Hospira slowly ramps up production. Article

> GlaxoSmithKline pulls vaccines after bacteria found in plant. News

And Finally... Fictional vampires originally sprang from the fear of inexplicable diseases, a new book posits. Report

Suggested Articles

J&J's talc woes deepened Friday after the FDA turned up "sub-trace" levels of asbestos one bottle of the company's baby powder,…

Another major drugmaker is recalling in the U.K. 10 batches of its Zantac generics because they contain a possible carcinogen.

With diagnosis rates on the rise, Pfizer's Vyndaqel franchise could collect $157 million in 2019 U.S. sales, well above consensus, SVB Leerink says.